| Advantage Home Health Services Central | |
| 1368 South Atherton Street, State College, Pennsylvania 16801 | |
| (814) 235-1011 | |
| Name | Advantage Home Health Services Central |
|---|---|
| Location | 1368 South Atherton Street, State College, Pennsylvania |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 397564 |
| Ownership Type | Proprietary |
| Service Area Zip Codes | 15853, 15857, 15868, 16823, 17006, 17014, 17021, 17035, 17044, 17047, 17049, 17058, 17059, 17062, 17074, 17082, 17086, 17094 |
| NPI Number | 1275589566 |
| Organization Name | IN-HOME CARE SERVICES LLC |
| Address | 1368 South Atherton Street, State College, PA 16801 |
| Phone Number | 814-235-1011 |
News Archive
Everyone grows older, but scientists don't really understand why. Now a UCLA study has uncovered a biological clock embedded in our genomes that may shed light on why our bodies age and how we can slow the process.
Copayment Reductions Generate Greater Medication Adherence In Targeted Patients. As health care costs have increased, some patients have sought to save money by cutting down on their medications.
The beneficial effects of nanotechnology innovation on human health and the environment are the focus of a comprehensive report to be presented at the Nano Science and Technology Institute's Nanotech Conference and Expo 2010 in Anaheim, CA, June 21-24, 2010. The report, titled "Nanotechnology, Health and the Environment," was authored by shareholders of the international law firm Greenberg Traurig, LLP; the managing director of Intertox, Inc.,
Bio-Path Holdings, Inc.,, a biotechnology company with drug development operations in Houston, Texas, announced today that the first patient has been dosed in a Phase I study of its cancer drug candidate, Liposomal Grb-2 (L-Grb-2 or BP-100-1.01), in patients with Acute Myeloid Leukemia (AML), Chronic Myelogenous Leukemia (CML), Acute Lymphoblastic Leukemia (ALL) or Myelodysplastic Syndrome (MDS).
› Verified 9 days ago
| Quality Rating: |
News Archive
Everyone grows older, but scientists don't really understand why. Now a UCLA study has uncovered a biological clock embedded in our genomes that may shed light on why our bodies age and how we can slow the process.
Copayment Reductions Generate Greater Medication Adherence In Targeted Patients. As health care costs have increased, some patients have sought to save money by cutting down on their medications.
The beneficial effects of nanotechnology innovation on human health and the environment are the focus of a comprehensive report to be presented at the Nano Science and Technology Institute's Nanotech Conference and Expo 2010 in Anaheim, CA, June 21-24, 2010. The report, titled "Nanotechnology, Health and the Environment," was authored by shareholders of the international law firm Greenberg Traurig, LLP; the managing director of Intertox, Inc.,
Bio-Path Holdings, Inc.,, a biotechnology company with drug development operations in Houston, Texas, announced today that the first patient has been dosed in a Phase I study of its cancer drug candidate, Liposomal Grb-2 (L-Grb-2 or BP-100-1.01), in patients with Acute Myeloid Leukemia (AML), Chronic Myelogenous Leukemia (CML), Acute Lymphoblastic Leukemia (ALL) or Myelodysplastic Syndrome (MDS).
› Verified 9 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 100 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 100 | 98.6 |
| How often the home health team checked patients’ risk of falling | 100 | 99.6 |
| How often the home health team checked patients for depression | 100 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 80 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 75.5 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 100 | 96.4 |
News Archive
Everyone grows older, but scientists don't really understand why. Now a UCLA study has uncovered a biological clock embedded in our genomes that may shed light on why our bodies age and how we can slow the process.
Copayment Reductions Generate Greater Medication Adherence In Targeted Patients. As health care costs have increased, some patients have sought to save money by cutting down on their medications.
The beneficial effects of nanotechnology innovation on human health and the environment are the focus of a comprehensive report to be presented at the Nano Science and Technology Institute's Nanotech Conference and Expo 2010 in Anaheim, CA, June 21-24, 2010. The report, titled "Nanotechnology, Health and the Environment," was authored by shareholders of the international law firm Greenberg Traurig, LLP; the managing director of Intertox, Inc.,
Bio-Path Holdings, Inc.,, a biotechnology company with drug development operations in Houston, Texas, announced today that the first patient has been dosed in a Phase I study of its cancer drug candidate, Liposomal Grb-2 (L-Grb-2 or BP-100-1.01), in patients with Acute Myeloid Leukemia (AML), Chronic Myelogenous Leukemia (CML), Acute Lymphoblastic Leukemia (ALL) or Myelodysplastic Syndrome (MDS).
› Verified 9 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 66.8 | 79.6 |
| How often patients got better at getting in and out of bed | 76.2 | 81.1 |
| How often patients got better at bathing | 68.1 | 82.3 |
| How often patients’ breathing improved | 69.1 | 82.8 |
| How often patients’ wounds improved or healed after an operation | - | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 60.2 | 75 |
| How often home health patients had to be admitted to the hospital | 17 | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 14.6 | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 99.2 | 94 |
News Archive
Everyone grows older, but scientists don't really understand why. Now a UCLA study has uncovered a biological clock embedded in our genomes that may shed light on why our bodies age and how we can slow the process.
Copayment Reductions Generate Greater Medication Adherence In Targeted Patients. As health care costs have increased, some patients have sought to save money by cutting down on their medications.
The beneficial effects of nanotechnology innovation on human health and the environment are the focus of a comprehensive report to be presented at the Nano Science and Technology Institute's Nanotech Conference and Expo 2010 in Anaheim, CA, June 21-24, 2010. The report, titled "Nanotechnology, Health and the Environment," was authored by shareholders of the international law firm Greenberg Traurig, LLP; the managing director of Intertox, Inc.,
Bio-Path Holdings, Inc.,, a biotechnology company with drug development operations in Houston, Texas, announced today that the first patient has been dosed in a Phase I study of its cancer drug candidate, Liposomal Grb-2 (L-Grb-2 or BP-100-1.01), in patients with Acute Myeloid Leukemia (AML), Chronic Myelogenous Leukemia (CML), Acute Lymphoblastic Leukemia (ALL) or Myelodysplastic Syndrome (MDS).
› Verified 9 days ago
News Archive
Everyone grows older, but scientists don't really understand why. Now a UCLA study has uncovered a biological clock embedded in our genomes that may shed light on why our bodies age and how we can slow the process.
Copayment Reductions Generate Greater Medication Adherence In Targeted Patients. As health care costs have increased, some patients have sought to save money by cutting down on their medications.
The beneficial effects of nanotechnology innovation on human health and the environment are the focus of a comprehensive report to be presented at the Nano Science and Technology Institute's Nanotech Conference and Expo 2010 in Anaheim, CA, June 21-24, 2010. The report, titled "Nanotechnology, Health and the Environment," was authored by shareholders of the international law firm Greenberg Traurig, LLP; the managing director of Intertox, Inc.,
Bio-Path Holdings, Inc.,, a biotechnology company with drug development operations in Houston, Texas, announced today that the first patient has been dosed in a Phase I study of its cancer drug candidate, Liposomal Grb-2 (L-Grb-2 or BP-100-1.01), in patients with Acute Myeloid Leukemia (AML), Chronic Myelogenous Leukemia (CML), Acute Lymphoblastic Leukemia (ALL) or Myelodysplastic Syndrome (MDS).
› Verified 9 days ago
Centre Homecare Inc Location: 2437 East College Avenue Suite 6, State College, Pennsylvania 16801 Ratings: Phone: (814) 237-7400 | |
Advantage Home Health Services Central Location: 1368 South Atherton Street, State College, Pennsylvania 16801 Ratings: Phone: (814) 235-1011 | |
Aveanna Healthcare Location: 1631 South Atherton Street, Suite 201, State College, Pennsylvania 16801 Ratings: NA Phone: (814) 235-9583 | |
Medi Home Health Agency Location: 341 North Science Park Road Suite 207, State College, Pennsylvania 16803 Ratings: Phone: (814) 235-1048 | |
Bayada Home Health Care, Inc. Location: 2123 East College Avenue, Suite 200, State College, Pennsylvania 16801 Ratings: NA Phone: (814) 235-9200 | |
Ekidzcare Location: 270 Walker Drive Suite 205, State College, Pennsylvania 16803 Ratings: NA Phone: (814) 308-9510 |